Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccination plus previous infection: protection during the omicron wave in Brazil
Thiago Cerqueira‐Silva, Vinícius de Araújo Oliveira, Enny S. Paixão, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 945-946
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Profile and Outcomes of Hospitalized COVID-19 Patients during the Prevalence of the Omicron Variant According to the Brazilian Regions: A Retrospective Cohort Study from 2022
Pedro Dutra Drummond, Daniel Bortot de Salles, Natália Satchiko Hojo de Souza, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1568-1568
Open Access | Times Cited: 3
Maintenance of Antibody Response in Egyptian Healthcare Workers Vaccinated with ChAdOx1 nCoV-19 Vaccine during Delta and Omicron Variants Pandemic: A Prospective Study
Noha M. Hammad, Heba M. Kadry, Mai Malek, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1706-1706
Open Access | Times Cited: 4
Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection
Huiling Zheng, Shenggen Wu, Chen Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M TM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
Vivek Shinde, Anthonet Koen, Zaheer Hoosain, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022
Reshma Kassanjee, Mary‐Ann Davies, Alexa Heekes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Omicron BA.4/5 neutralization and cell‐mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow‐up cohort study
Haoting Zhan, Yuchen Xie, Yongmei Liu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access
The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2
Madison Stoddard, Yuan Lin, Sharanya Sarkar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Adolescent COVID-19 Cases During the SARS-CoV-2 Delta and Omicron Variant Surges in Kentucky: Association With Vaccination and Prior Infection
Kevin B. Spicer, Connor Glick, Douglas Thoroughman
Journal of Adolescent Health (2023) Vol. 73, Iss. 3, pp. 536-542
Open Access | Times Cited: 1
Projecting the potential impact of an Omicron XBB.1.5 wave in Shanghai, China
Hengcong Liu, Xiangyanyu Xu, Xiaowei Deng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in Amazonas, a Brazilian setting with high levels of hybrid immunity
Ighor Arantes, Gonzalo Bello, Valdinete Alves do Nascimento, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Mitigation of Socio-Economical Inequalities on the Profile of Healthcare Workers Infected with SARS-CoV-2 upon Vaccination: The Experience of a Brazilian Public Healthcare Institution during the Omicron Wave
Maria Célia Chaves Zuma, Roberta Soares Faccion, Ana Carolina Carioca da Costa, et al.
COVID (2023) Vol. 3, Iss. 1, pp. 65-81
Open Access
SARS‐CoV‐2 mRNA vaccine: Sometimes life needs a boost
Carson K. L. Lo, Deepali Kumar
Transplant Infectious Disease (2023) Vol. 25, Iss. 5
Open Access
Antibody response following the fourth SARS‐CoV‐2 vaccine dose during the Omicron wave in Brazil
Maria Francilene Souza Silva, Fátima de Cássia Evangelista de Oliveira, Ana Carolina Matias Dinelly Pinto, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access
COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test-negative design
Sandra Irala, Sarah Hamid, Elena Penayo, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6453-6460
Closed Access
Impact of Vaccination and Nonpharmaceutical Interventions With Possible COVID-19 Viral Evolutions Using an Agent-Based Simulation
Serin Lee, Zelda B. Zabinsky, Judith N. Wasserheit, et al.
AJPM Focus (2023) Vol. 3, Iss. 1, pp. 100155-100155
Open Access
Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022
Iris Finci, Madelyn Yiseth Rojas Castro, Nabil Seyidov, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Importancia de la diferenciación de la respuesta inmune humoral entre individuos convalecientes, vacunados, y casos incidentes de COVID-19
Luisa F. Duarte, Yaneisi Vásquez, Benjamín Diethelm‐Varela, et al.
Revista del Instituto de Salud Pública de Chile (2023) Vol. 7, Iss. 1
Open Access
Effectiveness of Inactivated SARS-CoV-2 Vaccines During a Delta Variant Outbreak in Hunan Province, China: A Retrospective Cohort Study
Xuemei Yan, Zhihui Dai, Qianhui Wu, et al.
Zoonoses (2022) Vol. 2, Iss. 1
Open Access
Immunity Acquired From the First Wave of COVID-19 Against Reinfections Up to Omicron Predominance
Fan‐Yun Lan, Stephen D. Kasteler, Amalia Sidossis, et al.
Mayo Clinic Proceedings (2022) Vol. 98, Iss. 1, pp. 202-203
Open Access
Previous Page - Page 2

Scroll to top